Red and Blotchy Palms: Differential Diagnosis and Clinical Approach

Initial Clinical Assessment

• The Centers for Disease Control and Prevention recommends considering Rocky Mountain spotted fever (RMSF) if fever and systemic symptoms are present with recent tick exposure, which presents with maculopapular rash spreading to palms and soles 2-4 days after fever onset, with 5-10% mortality if untreated 1, 2, 3
• The American Society of Clinical Oncology notes that hand-foot syndrome (palmar-plantar erythrodysesthesia) causes redness, marked discomfort, swelling and tingling, occurring in 6-60% of patients on agents like capecitabine, 5-FU, or doxorubicin 4

Life-Threatening Causes to Rule Out First

• The Centers for Disease Control and Prevention recommends urgent doxycycline treatment for Rocky Mountain spotted fever; delay increases mortality from 5% to potentially fatal outcomes 1, 2, 3
• The Centers for Disease Control and Prevention states that ehrlichiosis presents with fever, headache, and rash involving palms/soles in 30% of adults and 60% of children, with 3% case-fatality rate 1, 2

Common Secondary Causes by System

Dermatologic Conditions

• The American Academy of Dermatology recommends topical clobetasol solution for scalp involvement in palmoplantar psoriasis, and oral acitretin (25mg daily) shows substantial improvement within 2 months for severe palmar involvement 5
• The American Academy of Dermatology notes that irritant contact dermatitis can be caused by frequent hand washing, especially during COVID-19 precautions, and water temperature >40°C increases risk 6

Systematic Diagnostic Algorithm

• The Centers for Disease Control and Prevention recommends treating empirically for RMSF with doxycycline if fever, palmar rash, and tick exposure are present 1, 2, 3

Critical Pitfalls to Avoid

• The Centers for Disease Control and Prevention warns against waiting for the classic triad (fever, rash, tick bite) before treating suspected RMSF – only a minority present with all three initially, and delayed treatment increases mortality 1, 3

Treatment Approach

• The American Society of Clinical Oncology recommends continuing drug and applying topical low/moderate steroid for Grade 1 chemotherapy-induced hand-foot syndrome, and interrupting treatment until Grade 0/1, using oral antibiotics, topical steroids, and considering systemic corticosteroids for Grade ≥3 4
• The American Academy of Dermatology recommends topical clobetasol solution, oral acitretin, soak PUVA, or 308-nm excimer laser for palmoplantar psoriasis 5
• The American Academy of Dermatology suggests applying moisturizer after every hand wash, using lukewarm water, and applying moderate-to-high potency topical corticosteroids for irritant contact dermatitis 6, 7

Drug-Induced Palmar Erythema

Chemotherapy-Induced Hand-Foot Syndrome

• Chemotherapy-induced Hand-Foot Syndrome (HFS) causes redness, marked discomfort, swelling, and tingling in palms, occurring in 6-60% of patients on capecitabine, 5-FU (6-34%), doxorubicin (22-29%), or PEGylated liposomal doxorubicin (40-50%) 8
• Symptoms develop within days to weeks after therapy initiation, though may take up to 6 months depending on pharmacokinetics 8
• Hand-foot skin reaction (HFSR) from BRAF inhibitors (vemurafenib, dabrafenib) or multikinase VEGFR inhibitors (sorafenib 10-62%, cabozantinib 40-60%, sunitinib 10-50%, regorafenib 47%) presents with well-defined painful hyperkeratosis rather than the classic HFS pattern 8
• The management approach for Grade 1-2 HFS is to continue the drug and apply topical low/moderate steroid; for Grade ≥3, interrupt treatment until Grade 0/1, use oral antibiotics (doxycycline 100mg b.i.d. for 6 weeks), topical steroids, and consider systemic corticosteroids 8

Psoriatic Arthritis and Spondyloarthritis

• Erythrodermic psoriasis can present with superficial exfoliation of palms and pitting edema of extremities, according to the American Academy of Dermatology 9, 10

Management of Bilateral Palmar‑Plant​ar Erythema with Axillary Involvement

1. Differential Diagnosis – Psoriasis‑Centric Perspective

• Inverse psoriasis is especially characteristic when erythema involves axillary skin folds together with bilateral palmoplantar lesions, distinguishing it from other causes such as dyshidrotic eczema or contact dermatitis. [11][12]
• Inverse psoriasis typically presents as erythematous plaques with minimal scaling in intertriginous sites (axillae, genital, perineal, intergluteal, inframammary areas). [11][12]
• The coexistence of bilateral palmoplantar lesions and axillary plaques strongly points to psoriasis, because the disease frequently affects both flexural and palmoplantar regions simultaneously. 13
• Palmoplantar psoriasis appears as well‑demarcated red plaques bearing silvery scale and can be intensely pruritic despite involving a small body‑surface area. 13
• A combined palmoplantar‑inverse pattern is common in psoriatic disease; psoriasis may involve any skin region, including hands, feet, and flexural surfaces. [13][11]
• Irritant contact dermatitis can produce erythema, scaling, and pruritus on the palms after frequent washing or chemical exposure, and may extend to the axillae from deodorants or clothing irritants, but the symmetric palmoplantar‑axillary distribution is less typical for this condition. 13

2. Key Historical Elements Supporting Psoriasis

• Positive personal or family history of psoriasis or other autoimmune disorders increases the likelihood of a psoriatic etiology. [13][11]
• Recent occupational exposure to new irritants (e.g., soaps, chemicals, gloves) should be queried to differentiate contact dermatitis from psoriasis. 13

3. Physical Examination Findings that Favor Psoriasis

• Presence of well‑demarcated erythematous plaques with silvery scale on palms, soles, or other typical sites (scalp, elbows, knees, genital area) is indicative of psoriasis. 13
• Axillary lesions that exhibit minimal scaling are characteristic of inverse psoriasis. [11][12]
• Nail changes such as pitting, onycholysis, subungual hyperkeratosis, or the “oil‑drop” sign support a diagnosis of psoriatic onychodystrophy. [11][12]

4. First‑Line Therapeutic Approach for Suspected Psoriasis

• Initiate high‑potency topical corticosteroids (e.g., clobetasol 0.05 % cream/ointment) applied twice daily to palmoplantar plaques.
• Apply moderate‑potency corticosteroids to axillary areas to avoid excessive absorption and skin atrophy in intertriginous zones. 13
• Encourage liberal use of emollients on all affected sites to improve barrier function and reduce irritation. 13

5. Escalation Strategies When Topical Therapy Is Inadequate

• If there is insufficient response after 4 weeks of optimized topical treatment, refer for topical PUVA (psoralen + UVA) administered 2–3 sessions per week; this regimen achieves clearance in 50–67 % of hyperkeratotic eczema and is effective for palmoplantar psoriasis. 14

6. Adjunctive Measures

• “Soak‑and‑smear” technique: soak hands in plain water for ~20 minutes, then apply moisturizer to damp skin to enhance drug penetration. (clinical practice point, no citation).
• For contact dermatitis, identify and eliminate the offending irritant or allergen in addition to using appropriate topical corticosteroids. 13

7. Clinical Pitfalls and Quality‑of‑Life Considerations

• Palmoplantar involvement, although limited in surface area, disproportionately impairs quality of life; systemic therapy should be considered when topical measures fail. 13
• A thorough medication review is essential because drug‑induced dermatoses (e.g., chemotherapy‑related hand‑foot syndrome) require immediate cessation of the offending agent. 15